CNS Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is…

Biotechnology
US, Houston [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared CNS Pharmaceuticals, Inc. (CNSP) to it's peer group.

Peer Group
Loading...
End of CNSP's Analysis
CIK: 1729427 CUSIP: 18978H102 ISIN: US18978H2013 LEI: - UEI: -
Secondary Listings
CNSP has no secondary listings inside our databases.